Andrew Placzek

Company: Schrodinger Inc

Job title: Principal Scientist

Seminars:

Discovery of Novel & Potent Inhibitors Targeting the NLRP3 Pathway 11:00 am

Using the physic-based computational platform, allied with machine learning techniques to enable the identification of NLRP3 inhibitors Highlighting the inhibitor’s capability to target both peripheral and CNS diseases Harnessing a range of functional and mechanistic cellular assays, in vivo pharmacodynamic and disease models to explore pathway inhibitionRead more

day: Conf Day 2